Discover
OM
Outset Medical, Inc.
3.15
1 x 3.13
2 x 3.90
bid
ask
+
0.05
1.61%
2 @ 07:30 PM
3.17 +0.02 (0.51%)
| Ytd | -15.09% | |
| 1y | -77.77% |
3.02
day range
3.15
3.00
52 week range
16.16
| Open | 3.10 | Prev Close | 3.10 | Low | 3.02 | High | 3.15 | Mkt Cap | 59.21M |
| Vol | 186.71K | Avg Vol | 186.54K | EPS | -3.80 | P/E | N/A | Forward P/E | -0.89 |
| Beta | 1.95 | Short Ratio | 2.94 | Inst. Own | 52.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 4.16 | 200-d Avg | 4.20 | 1yr Est | 4.00 |
| Income Statement | |||
| Total Revenue | 31.64M | ||
| Revenues (USD) | 31.64M | ||
| Cost of Revenue | 18.35M | ||
| Gross Profit | 13.28M | ||
| Operating Expenses | 28.96M | ||
| Research and Development Expense | 5.45M | ||
| Selling, General and Administrative Expense | 23.51M | ||
| Operating Income | -15.68M | ||
| Interest Expense | 3.44M | ||
| Income Tax Expense | 220.00K | ||
| Net Income | -17.98M | ||
| Net Income Common Stock | -17.98M | ||
| Net Income Common Stock (USD) | -17.98M | ||
| Consolidated Income | -17.98M | ||
| Earnings per Basic Share | -0.97 | ||
| Earnings per Basic Share (USD) | -0.97 | ||
| Earnings per Diluted Share | -0.97 | ||
| Earning Before Interest & Taxes (EBIT) | -14.32M | ||
| Earning Before Interest & Taxes (USD) | -14.32M | ||
| Weighted Average Shares | 18.62M | ||
| Weighted Average Shares Diluted | 18.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 38.83M | ||
| Cash and Equivalents (USD) | 38.83M | ||
| Investments | 112.19M | ||
| Investments Current | 112.19M | ||
| Trade and Non-Trade Receivables | 29.22M | ||
| Current Assets | 227.85M | ||
| Property, Plant & Equipment Net | 10.30M | ||
| Total Assets | 242.39M | ||
| Debt Current | 2.59M | ||
| Total Debt | 104.45M | ||
| Current Liabilities | 43.89M | ||
| Debt Non-Current | 101.86M | ||
| Total Liabilities | 146.05M | ||
| Accumulated Retained Earnings (Deficit) | -1.21B | ||
| Accumulated Other Comprehensive Income | -136.00K | ||
| Shareholders Equity | 96.34M | ||
| Shareholders Equity (USD) | 96.34M | ||
| Assets Non-Current | 14.54M | ||
| Total Debt (USD) | 104.45M | ||
| Deferred Revenue | 14.35M | ||
| Inventory | 47.32M | ||
| Liabilities Non-Current | 102.16M | ||
| Trade and Non-Trade Payables | 4.46M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.05M | ||
| Net Cash Flow from Financing | -88.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.44M | ||
| Capital Expenditure | -111.00K | ||
| Issuance (Repayment) of Debt Securities | -88.00K | ||
| Net Cash Flow from Investing | 14.17M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.28M | ||
| Net Cash Flow from Operations | -9.63M | ||
| Share Based Compensation | 2.70M | ||